Medipal Holdings announced group personnel changes on 8 September. Imagawa Kuniaki (今川 国明) will be promoted to representative director and president, while Mediceo will also welcome a new president.
Medipal Holdings announced that Watanabe Shuichi (渡辺 秀一), representative director and chairman of the holding company, will continue in his current role, while Imagawa Kuniaki (今川 国明) will be promoted to representative director and president. Imagawa Kuniaki (今川 国明) will oversee the pharmaceutical business and establish a new management structure as the group's top executive.
Utsumi Osamu (内海 修) will become Mediceo's new president. In connection with this change, Chofuku Yasuhiro (長福 恭弘) is scheduled to change from representative director and chairman to director and senior adviser, while Watanabe Shuichi (渡辺 秀一), the new chairman of the holding company, is also scheduled to change to director and senior adviser. Under the new structure, he will also serve as chairman of Mediceo.
Following the appointment of Imagawa Kuniaki (今川 国明), Utsumi Osamu (内海 修) will become Mediceo's new president, while Hara Chitose (原 千年), formerly head of the West Japan Branch, will be newly appointed as an executive officer. Komune Kin'i (小宗 均伊), Ii Terumi (井伊 輝副美) and Sera Masahito (世良 正仁) will also serve as executive officers overseeing divisions of the West Japan Branch.
The personnel changes will take effect on 1 October and include changes to executive positions and executive officer responsibilities at both Medipal Holdings and Mediceo. The companies aim to enhance corporate value and promote growth under the new structure.